Mabel M. Ryder

6.1k citations
69 papers · 4.8k · 3 hit papers · h-index 27

Impact in

    • Thyroid Cancer Diagnosis and Treatment
  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • Cancer-related Molecular Pathways
    • CAR-T cell therapy research
    • Colorectal Cancer Treatments and Studies

Papers in

    • Thyroid Cancer Diagnosis and Treatment 32
    • Cancer Immunotherapy and Biomarkers 15
    • Colorectal Cancer Treatments and Studies 6
    • CAR-T cell therapy research 4
    • Cancer-related Molecular Pathways 4

Mabel M. Ryder

66 papers receiving 4.7k citations

Mabel M. Ryder's Hit Papers

Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology 2022 · 334 citations
3340+2+4Years since publication100200300400

Peers

Mabel M. Ryder
Comparison fields: 5 of 93
  • Endocrinology, Diabetes and Metabolism 1.9k
  • Oncology 2.4k
  • Cancer Research 270
  • Immunology 384
  • Pathology and Forensic Medicine 310
Replace Naifa Lamki Busaidy with:
Naifa Lamki Busaidy United States
Tchao Méatchi France
Aleš Ryška Czechia
Paxton Vandiver Dickson United States
David Viola Italy
Tadao Nakazawa Japan
Mouhammed Amir Habra United States
Dong Eun Song South Korea
Carol Peña United States
Isabelle Soubeyran France
Mabel M. Ryder relative to Naifa Lamki Busaidy United States Naifa Lamki Busaidy's profile →
Citations per field
00.5×2×2.8×
Naifa Lamki Busaidy · 1×
Citations per year

Countries citing papers authored by Mabel M. Ryder

Since Specialization
Citations

This map shows the geographic impact of Mabel M. Ryder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mabel M. Ryder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mabel M. Ryder more than expected).

Fields of papers citing papers by Mabel M. Ryder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mabel M. Ryder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mabel M. Ryder. The network helps show where Mabel M. Ryder may publish in the future.

Co-authors

The 25 scholars most cited alongside Mabel M. Ryder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mabel M. Ryder Line = papers co-authored together Mabel M. Ryder links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
Hit paper breakdown →
2019469
2 2009455
3
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020
Hit paper breakdown →
2020411
4 2014379
5 2013336
6
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology
Hit paper breakdown →
2022334
7 2011314
8 2019274
9 2017212
10 2019137
11 2013122
12 2017114
13 2021107
14 201799
15 202285
16 202469
17 201668
18 202065
19 201963
20 201358

About Mabel M. Ryder

Mabel M. Ryder is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology, Radiology, Nuclear Medicine and Imaging, Surgery and Cancer Research, having authored 69 papers that have together received 4.8k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (32 papers), Cancer Immunotherapy and Biomarkers (15 papers), Colorectal Cancer Treatments and Studies (6 papers), Adrenal and Paraganglionic Tumors (6 papers), CAR-T cell therapy research (4 papers), Cancer-related Molecular Pathways (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and BRCA gene mutations in cancer (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.9k citations), Oncology (2.4k citations), Cancer Research (270 citations), Immunology (384 citations) and Pathology and Forensic Medicine (310 citations). Mabel M. Ryder has collaborated with scholars based in United States, Canada and India. Frequent co-authors include James A. Fagin, Jeffrey A. Knauf, Ronald A. Ghossein, Camilo Jiménez, Maria E. Cabanillas, Lisa A. Kottschade, Keith Christopher Bible, Margaret K. Callahan, Jedd D. Wolchok and Michael Andrew Postow. Their work appears in journals such as Thyroid, The Journal of Clinical Endocrinology & Metabolism, Journal of the National Comprehensive Cancer Network, Head & Neck and Endocrine Related Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact